ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Sagent Launches Phase 2 Trial to Evaluate Camostat Mesilate for COVID-19 americanpharmaceuticalreview
November 24, 2020Sagent Pharmaceuticals, a Nichi-Iko Group Company, has launched its Phase 2 CAMELOT trial to evaluate the safety and efficacy of Camostat Mesilate (Camostat) for the treatment of COVID-19 in high-risk outpatients and has begun enrolling patients.
Pharma Sources Insight July 2025
